Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,102 total articles
Genius Group Limited (NYSE American: GNS) issued a statement responding to an unusual spike in its share price and trading volume on May 27-28, 2026, confirming there are no undisclosed material developments to explain the activity. The company highlighted recent significant corporate initiatives including approval of an AI Treasury strategy target…
Talkspace, Inc., a leading virtual behavioral healthcare provider, announced that its stockholders have approved the acquisition by Universal Health Services (UHS). The merger is expected to complete in the third quarter of 2026 pending regulatory approvals and other customary closing conditions. The acquisition aims to expand access to high-qualit…
NeOnc Technologies Holdings (NASDAQ:NTHI) is gaining investor attention as it develops AI-enhanced delivery technologies aimed at overcoming challenges like the blood-brain barrier in treating aggressive brain cancers such as glioblastoma. Leveraging AI and precision medicine, NeOnc is positioned at the forefront of a shifting biotech paradigm focu…
Diana Shipping Inc., a global dry bulk vessel owner and operator, held its 2026 Annual Meeting virtually, where shareholders approved the election of three Class III directors and the appointment of Deloitte as independent auditors for the fiscal year. The company provides short to medium-term charter shipping services worldwide for commodities suc…
Northrim BanCorp, an Alaska-based community bank holding company, declared a quarterly cash dividend of $0.16 per share, payable June 18, 2026. This dividend reflects a yield of 2.59% based on the recent stock price. The announcement follows the company’s strong first quarter earnings, with net income rising to $13.7 million, up from previous quart…
Duluth Trading Co. has expanded and refreshed its Garden Shop both online and in over 60 retail stores, focusing on durable and functional gardening apparel and accessories for women and men. The refreshed collection includes best-selling Heirloom Gardening Bib Overalls for women with high customer ratings, new gardening pants, and an expanded men'…
BioNexus Gene Lab Corp. emphasized at the 2026 China–Malaysia Economic Cooperation Outlook Forum the shift in Malaysia-China biotech collaboration from mere trade to strategic co-development, clinical validation, and commercialization across ASEAN. The company highlights its role as an ASEAN hub for precision diagnostics, AI-driven healthcare data,…
Dynagas LNG Partners LP announced its Q1 2026 financial results, highlighting a net income increase to $17.4 million and earnings per common unit of $0.43, supported by 95.1% fleet utilization and an Adjusted EBITDA of $24.3 million. The Partnership benefits from long-term charters fully contracting its fleet, insulating it from immediate LNG shipp…
SRx Health Solutions announced a new investment in Uber Technologies, Inc. as part of portfolio adjustments including reduced exposure to Compass, Inc. and Bitcoin, and adding hedges in select international markets. This repositioning comes in response to the EMJX stress model turning negative after a sustained bullish period, prompting a more caut…
WISeKey International Holding Ltd. announced that its SEALCOIN platform has integrated the QAIT token as its utility token following QAIT's market launch on major cryptocurrency exchanges. This integration supports autonomous machine-to-machine transactions across various industry applications, underpinning a secure and scalable digital economy dri…
Clearmind Medicine Inc., a clinical-stage biotech company, announced the filing of a Japanese patent application for its proprietary non-hallucinogenic psychedelic-based compound MEAI, designed for treating depression. This move expands Clearmind's intellectual property portfolio globally and aligns with its focus on neuroplastogen-derived therapeu…
SkyAI, a Nasdaq-listed fintech company focused on agentic finance for the Global South, has appointed Arthur Levine as Chief Financial Officer. Levine brings over 30 years of expertise in public company finance, having successfully led IPOs and growth initiatives. His addition is expected to bolster SkyAI's financial operations and infrastructure t…
Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision and robotics solutions, announced the approval of five key proposals at its extraordinary general meeting held on May 29, 2026. These include a 16-for-1 share consolidation, a significant increase in authorized share capital from $50,000 to $80 million, am…
Palomar Holdings, Inc. announced the successful completion of its June 1, 2026 reinsurance placement, boosting its earthquake and hurricane event coverage limits significantly. The company secured $421 million in additional limits, expanded its catastrophe bond issuance, and maintained prudent retention levels, resulting in an increased full-year 2…
Optimi Health Corp. acknowledged Australia's Therapeutic Goods Administration updated Authorized Prescriber framework, broadening therapist eligibility and treatment settings for psychedelic-assisted therapies using Optimi's MDMA and psilocybin products. These changes support scalable commercial growth as Australia leads globally in prescribed psyc…
Moleculin Biotech announced new data at ASCO 2026 demonstrating that Annamycin, their lead drug candidate, shows no detectable cardiotoxicity even at cumulative doses far exceeding conventional anthracycline limits. An independent review by Cleveland Clinic specialists supports a differentiated cardiac safety profile. The data bolster ongoing pivot…
Science Applications International Corp. (SAIC) announced a cash dividend of $0.37 per share payable on July 24, 2026, to shareholders of record as of July 10, 2026. SAIC intends to continue quarterly dividend payments, subject to board approval each quarter, based on earnings and financial condition. The company is a leading mission integrator spe…
Rail Vision Ltd., a Nasdaq-listed company specializing in AI-integrated railway safety systems, has signed a non-binding MOU with Railserve Inc., a Marmon Rail company, to expand collaboration beyond a prior commercialization agreement. The partnership focuses on deploying Rail Vision's AI-based ShuntingYard systems to enhance rail yard operations,…
SAB Biotherapeutics announced that it will present clinical data on SAB-142, its lead immunotherapy candidate for newly diagnosed Stage 3 type 1 diabetes, at the American Diabetes Association's 2026 Scientific Sessions and the Federation of Clinical Immunology Societies 2026 Annual Meeting. The presentations will showcase SAB-142's safety, pharmaco…
LGI Homes, Inc. has announced the grand opening of Trails West, a new 529-home master-planned community in West Jacksonville, Florida. The community offers upgraded homes starting in the $240,000s, a variety of floor plans, and planned amenities aimed at families seeking affordability and quality in a fast-growing region. This development complemen…
PetMed Express, Inc., a leading online pet pharmacy, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on June 2, 2026 after market close. The company will also host a live conference call and webcast the same day to discuss these results.
Rhythm Pharmaceuticals announced that seven abstracts, including four late-breaking presentations, have been accepted for the Endocrine Society's Annual Meeting (ENDO 2026). These presentations will share new clinical data on setmelanotide and bivamelagon in treating rare neuroendocrine disorders such as Prader-Willi syndrome, acquired hypothalamic…
Tenaya Therapeutics, a clinical-stage biotech focused on gene therapies for heart disease, announced its participation in the Jefferies Global Healthcare Conference with CEO Faraz Ali presenting on June 4, 2026. The company highlighted its pipeline including gene therapies targeting hypertrophic cardiomyopathy and arrhythmogenic right ventricular c…
Tempest Therapeutics, a clinical-stage biotech company specializing in CAR-T cell therapies for cancer, announced the exercise of outstanding warrants at a reduced price, generating gross proceeds of about $2 million. The company also issued new unregistered short-term warrants with a potential to raise an additional $4 million if fully exercised, …
Replimune Group announced that after productive discussions with the FDA, the company will resubmit the Biologics License Application for RP1 combined with nivolumab to treat advanced melanoma. The FDA will prioritize the review recognizing the unmet medical need for patients who progressed on prior anti-PD-1 therapy, potentially expediting availab…
